tiprankstipranks
Palvella Therapeutics (PVLA)
NASDAQ:PVLA
US Market
Holding PVLA?
Track your performance easily

Palvella Therapeutics (PVLA) Financial Statements

595 Followers

Palvella Therapeutics Financial Overview

Palvella Therapeutics's market cap is currently ―. The company's EPS TTM is $-12.611; its P/E ratio is ―; Palvella Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue--$ 53.00K$ 19.52M$ 20.05M
Gross Profit--$ 53.00K$ 19.52M$ 20.05M
EBIT$ -2.89M$ -3.59M$ -4.89M$ 3.09M$ 3.98M
EBITDA$ -2.89M$ -3.59M$ -4.89M$ 3.79M$ 3.98M
Net Income Common Stockholders$ -2.89M$ -3.59M$ -4.89M$ -10.75M$ 3.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.36M$ 19.73M$ 19.08M$ 44.81M$ 54.88M
Total Assets$ 20.52M$ 25.05M$ 29.50M$ 59.38M$ 87.54M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 4.25M$ 6.35M$ 7.53M$ 28.87M$ 47.05M
Stockholders Equity$ 16.27M$ 18.70M$ 21.96M$ 30.51M$ 40.50M
Cash Flow-
Free Cash Flow$ 288.00K$ 696.00K$ -7.00M$ -9.79M$ -13.50M
Operating Cash Flow$ 146.00K$ -1.48M$ -7.00M$ -9.72M$ -13.43M
Investing Cash Flow$ 142.00K$ 2.18M$ 9.00M$ -1.98M$ -1.37M
Financing Cash Flow----$ 19.78M
Currency in USD

Palvella Therapeutics Earnings and Revenue History

Palvella Therapeutics Debt to Assets

Palvella Therapeutics Cash Flow

Palvella Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis